These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4434527

  • 21. [Carbohydrate metabolism in female-patients with climacteric bleeding (author's transl)].
    Laurová L, Jandová A, Skoda V.
    Cesk Gynekol; 1974 Sep; 39(8):586-7. PubMed ID: 4434515
    [No Abstract] [Full Text] [Related]

  • 22. [Contraception with two low-dosage mestranol-norethisterone combinations].
    Tenhaeff D, Feldmann HU, Rupek R.
    Fortschr Med; 1972 Apr 20; 90(12):479-82. PubMed ID: 4641330
    [No Abstract] [Full Text] [Related]

  • 23. [Feedback--regulation mechanisms using a multiple graded mestranol-norethisterone sequential preparation in XO Turner's syndrome].
    Roll H, Breckwoldt M, Amann K.
    Arch Gynecol; 1979 Jul 20; 228(1-4):575-6. PubMed ID: 485482
    [No Abstract] [Full Text] [Related]

  • 24. [Use of an estroprogestinic association (norethindrone 2 mg and mestranol 100 gamma) in dysfunctional gynecologic syndromes].
    Capra A, Trompeo P, Garetto A, Campagnoli C.
    Minerva Ginecol; 1969 Aug 15; 21(15):967-86. PubMed ID: 5404341
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial.
    Franke HR, Snaaijer FF, Houben PW, van der Mooren MJ.
    Gynecol Endocrinol; 2006 Dec 15; 22(12):692-7. PubMed ID: 17162712
    [Abstract] [Full Text] [Related]

  • 26. [Actinotherapy of climacteric bleeding (author's transl)].
    Slot E.
    Cesk Gynekol; 1974 Sep 15; 39(8):616-7. PubMed ID: 4434529
    [No Abstract] [Full Text] [Related]

  • 27. A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters.
    Paterson ME.
    Maturitas; 1982 Aug 15; 4(2):83-94. PubMed ID: 6750325
    [Abstract] [Full Text] [Related]

  • 28. [LDH-activity in endometrium of female-patients with climacteric bleeding (author's transl)].
    Jandová A, Janousková M, Laurová L, Pezlarová J, Skoda V.
    Cesk Gynekol; 1974 Sep 15; 39(8):569-70. PubMed ID: 4434506
    [No Abstract] [Full Text] [Related]

  • 29. [An economic contribution to the prevention of climacteric bleeding].
    Kadrnková M, Soska J.
    Cesk Gynekol; 1986 Apr 15; 51(3):181-3. PubMed ID: 3719725
    [No Abstract] [Full Text] [Related]

  • 30. [The use of the Norcolut preparation in gynecologic; practice].
    Bozhinova S.
    Akush Ginekol (Sofiia); 1996 Apr 15; 35(3):50-1. PubMed ID: 9045566
    [Abstract] [Full Text] [Related]

  • 31. [Blood coagulation system indices in women with dysfunctional hemorrhage during treatment with infecundin].
    Manuilova IA, Aronovich AS, Tumanova AE.
    Sov Med; 1971 Jan 15; 34(1):27-30. PubMed ID: 5580234
    [No Abstract] [Full Text] [Related]

  • 32. Effects of the climacteric and sequential mestranol and norethisterone on the cervix and genital tract.
    Paterson ME, Allen J, Jordan JA.
    Br J Obstet Gynaecol; 1982 Aug 15; 89(8):657-64. PubMed ID: 7104258
    [Abstract] [Full Text] [Related]

  • 33. [The functional state of the liver in patients with dysfunctional uterine bleeding in the climacteric period].
    Ivanov BK.
    Zh Eksp Klin Med; 1967 Aug 15; 7(4):56-9. PubMed ID: 5633523
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical results and problems of oral contraceptives, a combination of norethindrone and mestranol (2)].
    Ueda Y, Hayashi K, Maruo M, Fujii O, Yagi T.
    Saishin Igaku; 1965 Dec 15; 20(12):3234-53 passim. PubMed ID: 5869520
    [No Abstract] [Full Text] [Related]

  • 35. [Restoration of the reproductive function in dysfunctional uterine hemorrhage patients under gestagenic steroid treatment].
    Prilepskaia VN.
    Vopr Okhr Materin Det; 1980 Mar 15; 25(3):59-63. PubMed ID: 7385674
    [Abstract] [Full Text] [Related]

  • 36. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy.
    Burnett D, Moore B, Williams JG, Studd JW, Bradwell AR.
    Postgrad Med J; 1976 Mar 15; 52 Suppl 6():48-51. PubMed ID: 981119
    [No Abstract] [Full Text] [Related]

  • 37. [Incidence and clinical study of dysfunctional bleeding in the preclimacteric and climacteric].
    Havlík I, Pavlík J, Sedlácková J, Havlíková S, Bárta L, Franĕk B, Trubacová Z.
    Cesk Gynekol; 1984 Jul 15; 49(6):418-21. PubMed ID: 6541528
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of dysmenorrhea with a mixed preparation of norethindrone and mestranol (S-3800C)].
    Karasawa Y.
    Sanfujinka No Jissai; 1968 Oct 15; 17(10):913-8. PubMed ID: 5755772
    [No Abstract] [Full Text] [Related]

  • 39. [Our experience with orally administered norethisterone in the prevention of climacteric metrorrhagia].
    Soska J, Srácek J.
    Cesk Gynekol; 1966 Feb 15; 31(1):118-9. PubMed ID: 5930091
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment effectiveness in dysfunctional uterine hemorrhages using the gestagen, Norcolut].
    Prilepskaia VN, Kulakov VI, Baklaenko NG, Laricheva IP.
    Akush Ginekol (Mosk); 1979 Oct 15; (10):29-31. PubMed ID: 507332
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.